John P Kelley
CIK 1310470 · Chief Executive Officer · last filed 2023-06-23
John P Kelley is a Chief Executive Officer who has filed 27 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ACOR, was dated Jun 23, 2023. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.73M
4
27
-$2.96M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Acorda Therapeutics, Inc. (ACOR) Delisted | Director | 10,000 | $0.66 | $6.6K | -$1.41M | 18 | 2023-06-23 |
| TENX | Chief Executive Officer | 1,282,932 | $11.48 | $14.73M | $0 | 2 | 2017-03-20 |
| TENAX THERAPEUTICS, INC. (OXBT) Delisted | Chief Executive Officer | 341,711 | — | — | $0 | 1 | 2013-11-15 |
| MEDICINES CO /DE (MDCO) Delisted | President and COO | 55,615 | — | — | -$1.55M | 6 | 2009-02-24 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-23 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-14 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-17 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-21 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-29 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-02 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-20 | TENX | Mixed | +116,421 | -$66.0K | EDGAR |
| 2016-12-20 | TENX | Grant (A) | — | $0 | EDGAR |
| 2016-06-10 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |